Atyr Pharma Director Paul Schimmel Reported Purchase Of 100,000 Shares @ Avg Price Of $1.85/Share In Form 4 Filing On Wednesday
Portfolio Pulse from charles@benzinga.com
Atyr Pharma Director Paul Schimmel reported the purchase of 100,000 shares at an average price of $1.85 per share, as disclosed in a Form 4 filing on Wednesday.
July 25, 2024 | 9:10 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Atyr Pharma Director Paul Schimmel's purchase of 100,000 shares at $1.85 per share indicates confidence in the company's future prospects.
Insider purchases are often seen as a positive signal by investors, indicating that those with the most knowledge of the company believe in its future success. This could lead to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100